Forensic Fluids Laboratories INC.

Forensic Fluids Laboratories INC. was paid $10.23M by Medicaid between Jan 2018 and Dec 2024, across 38 billing codes. Its largest line is G0481, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed — 40% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Michigan

Rank by total paid#12 of 108

Median peer was paid$588K

This provider vs. median17×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	71,485	$1.16M
2019	37,039	$971K
2020	16,855	$807K
2021	19,592	$1.27M
2022	26,410	$1.92M
2023	32,855	$2.13M
2024incomplete	29,207	$1.97M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	40%	47,297	38,470	$4.10M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	28%	79,795	60,423	$2.89M
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	16%	14,949	11,778	$1.65M
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	9.4%	12,146	9,346	$965K
80299		1.9%	2,079	1,118	$191K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	1.1%	1,090	850	$115K
80369		<1%	5,158	2,289	$30K
80373		<1%	5,745	2,641	$28K
80346		<1%	5,566	2,482	$28K
80361		<1%	5,802	2,666	$27K
80329		<1%	4,446	2,165	$26K
80324		<1%	5,802	2,683	$24K

26 more codes

80354		<1%	5,762	$22K
80365		<1%	5,778	$22K
80358		<1%	5,763	$21K
80353		<1%	5,771	$21K
80348		<1%	5,489	$21K
80356		<1%	5,705	$20K
80338		<1%	1,373	$5K
80332		<1%	1,058	$4K
80342		<1%	493	$3K
80355		<1%	1,123	$3K
80362		<1%	1,041	$3K
80339		<1%	722	$2K
80375		<1%	303	$2K
80366		<1%	606	$2K
80368		<1%	551	$1K
80370		<1%	493	$1K
80349		<1%	194	$1K
80323		<1%	336	$916.81
80347		<1%	120	$874.55
80143		<1%	93	$856.79
83992		<1%	178	$743.13
80357		<1%	128	$532.00
80345		<1%	137	$506.56
80367		<1%	121	$486.51
80371		<1%	114	$417.90
80350		<1%	116	$417.90

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLEMBERG, BRIDGET (LAB DIRECTOR)